Deutsche Bank Ag\ Medicenna Therapeutics Corp. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.53 - $2.85 $35,037 - $65,265	-22,900 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$1.91 - $3.05 $28,077 - $44,835	14,700 Added 179.27%	22,900 $64,000
Q2 2021 Aug 11, 2021	BUY	$2.97 - $4.28 $2,376 - $3,424	800 Added 10.81%	8,200 $25,000
Q1 2021 May 13, 2021	SELL	$3.5 - $4.56 $126,700 - $165,072	-36,200 Reduced 83.03%	7,400 $30,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $5.97 $161,320 - $260,292	43,600 New	43,600 $204,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.